Sale disclosed
John Leite
Global Chief Commercial Off
Common Stock
- Reported value
- $160.6K
- Reported price
- $40.00 / share
Loading data…Scanning SEC filings…Checking Congress reports…Following the signal…
VERACYTE, INC.
Last 30 daysNo qualifying insider buying. Sales: $365.35K by 2 insiders.
Showing the first 6 of 21 trades on this page.
Global Chief Commercial Off
Common Stock
Director
Common Stock
Chief Scientific & Med Officer
Common Stock
Chief Scientific & Med Officer
Common Stock
Chief Financial Officer
Common Stock
Chief Financial Officer
Common Stock
EVP, General Counsel
Common Stock
EVP, General Counsel
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
EVP, General Counsel
Common Stock
EVP, General Counsel
Common Stock
Chief Financial Officer
Common Stock
Chief Financial Officer
Common Stock
Chief Executive Officer
Common Stock
Global Chief Commercial Off
Common Stock
VP, Chief Accounting Officer
Common Stock
Director
Common Stock
SVP, General Counsel
Common Stock
SVP, General Counsel
Common Stock
| Reporting insider | Security / transaction | Amount / price | Value | Traded / disclosed | Source |
|---|---|---|---|---|---|
| Global Chief Commercial Off | Common StockSale10b5-1 | 4,015$40.00 / share | $160.6K | Sep 21Filed Sep 22 · 1d later | SEC filing |
| Director | Common StockSale10b5-1 | 5,000$40.95 / share | $204.75K | Sep 14Filed Sep 16 · 2d later | SEC filing |
| Chief Scientific & Med Officer | Common StockSale10b5-12 trades | 13,110avg $43.05 / share | $564.41K | Sep 4Filed Sep 4 · 0d later | 2 filings
|
| Chief Financial Officer | Common StockSale10b5-12 trades | 3,652avg $43.10 / share | $157.39K | Sep 4Filed Sep 4 · 0d later | 2 filings
|
| EVP, General Counsel | Common StockSale10b5-12 trades | 3,254avg $43.09 / share | $140.21K | Sep 4Filed Sep 4 · 0d later | 2 filings
|
| Director | Common StockSale10b5-1 | 1,864$42.97 / share | $80.1K | Sep 1Filed Sep 3 · 2d later | SEC filing |
| Director | Common StockSale10b5-12 trades | 3,729avg $52.89 / share | $197.23K | Jun 18Filed Jun 22 · 4d later | 2 filings
|
| EVP, General Counsel | Common StockSale10b5-12 trades | 3,176avg $49.76 / share | $158.04K | Jun 4Filed Jun 4 · 0d later | 2 filings
|
| Chief Financial Officer | Common StockSale10b5-12 trades | 3,561avg $49.73 / share | $177.08K | Jun 4Filed Jun 4 · 0d later | 2 filings
|
| Chief Executive Officer | Common StockSale10b5-1 | 138,051$50.12 / share | $6.92M | Jun 4Filed Jun 4 · 0d later | SEC filing |
| Global Chief Commercial Off | Common StockSale10b5-1 | 13,975$50.07 / share | $699.73K | Jun 4Filed Jun 4 · 0d later | SEC filing |
| VP, Chief Accounting Officer | Common StockSale | 24,000$45.40 / share | $1.09M | May 22Filed May 27 · 5d later | SEC filing |
| Director | Common StockSale10b5-1 | 10,000$44.01 / share | $440.13K | May 20Filed May 22 · 2d later | SEC filing |
| SVP, General Counsel | Common StockSale10b5-12 trades | 10,204avg $39.03 / share | $398.21K | May 6Filed May 8 · 2d later | 2 filings
|
Veracyte, Inc. - Common Stock (VCYT) · Stock
The filing reports a purchase for the member.
Gilbert CisnerosReporting House memberVeracyte, Inc. - Common Stock (VCYT) · Stock
The filing reports a purchase for the member.
Gilbert CisnerosReporting House memberVeracyte, Inc. - Common Stock (VCYT) · Stock
The filing reports a partial sale for the member.
Gilbert CisnerosReporting House memberNo eligible common-equity purchase is public by this cutoff within 180 transaction-date days. Other instruments, exercises and routine activity do not contribute purchase points.
This score describes qualifying insider purchases at issuer level. Read the methodology
Open a transaction's SEC filing for the primary evidence. A code P may describe an open-market or private purchase; classification is not proof of intent.
Insider activity can have many explanations. Signal Strength is not a probability of profit or a recommendation to trade.